Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.040
-0.030 (-2.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
Co-Diagnostics Employees
Co-Diagnostics had 155 employees as of December 31, 2023. The number of employees increased by 10 or 6.90% compared to the previous year.
Employees
155
Change (1Y)
10
Growth (1Y)
6.90%
Revenue / Employee
$47,232
Profits / Employee
-$266,350
Market Cap
33.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
HOOKIPA Pharma | 179 |
Precision Optics Corporation | 84 |
Surrozen | 42 |
Elevation Oncology | 29 |
Citius Pharmaceuticals | 22 |
Lantern Pharma | 21 |
Iterum Therapeutics | 14 |
CODX News
- 13 days ago - Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results - PRNewsWire
- 16 days ago - Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024 - PRNewsWire
- 26 days ago - Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - PRNewsWire
- 4 weeks ago - Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024 - PRNewsWire
- 7 weeks ago - Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - PRNewsWire
- 2 months ago - Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - PRNewsWire
- 2 months ago - Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test - PRNewsWire